Account Navigation

Account Navigation

Currency - All prices are in AUD

Currency - All prices are in AUD


EpiCypher has assembled a world-class leadership team that inspires confidence in our clients and employees, alike. They are particularly passionate about helping clients succeed using the latest in epigenetic research. To this end, they stay on the forefront of innovations and standardization initiatives, ensuring that the company offers the most sophisticated, yet flexible products, testing and services possible.

James Bone, Ph.D.
President & Co-founder

Jim earned a Bachelor of Science degree from the UNC Chapel Hill and a Ph.D. from Baylor College of Medicine. He was a post-doctoral fellow in Dr. Sharon Dent’s lab at the University of Texas MD Anderson Cancer Center and then later in the lab of Dr. C. David Allis at the University of Virginia Health Science Center. After leaving the Allis lab, Jim worked for Upstate Biotechnology (now part of EMD-Millipore) for six years, directing their efforts producing and selling products for chromatin biology and epigenetics research. After leaving Upstate, Jim was a founder of Lake Placid Biologicals, and worked later for Active Motif after their acquisition of the company.

Michael-Christopher Keogh, Ph.D.
Chief Scientific Officer

Michael earned his PhD in Molecular Immunology from Imperial College London and completed postdoctoral studies in the Thrombosis Research Institute (London) and with Dr. Steve Buratowski at Harvard Medical School. Prior to joining EpiCypher he was a Principal Investigator in the Department of Cell Biology at Albert Einstein College of Medicine. His work has focused on many key oncology research areas including cell-cycle regulation, DNA repair, epigenetics, gene expression and genetic networks.

Zu-Wen Sun, Ph.D.
Vice-President, Product Development

Dr. Sun joined EpiCypher after serving as an Assistant Professor in the Department of Biochemistry at Vanderbilt University School of Medicine. He received a Ph.D. from the LSU Health Sciences Center. He performed his post-doctoral studies with Dr. Michael Hampsey at the UMDNJ - Robert Wood Johnson Medical School and then later with Dr. C. David Allis at the University of Virginia Health Science Center. He is widely recognized for his pioneering work on understanding how histone ubiquitination affects chromatin structure and gene expression.